# Dyne Therapeutics, Inc.: Form 8-K, filed Feb 27, 2025

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: 8-K
- Filed: 2025-02-27
- Accepted by EDGAR: Feb 27, 2025, 12:35 ET
- Period: 2025-02-27
- Accession: 0000950170-25-028369
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000095017025028369/dyn-20250227.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000095017025028369/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000095017025028369/dyn-20250227.htm

Filed Feb 27, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-028369. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.